{"id":"https://openalex.org/W4414716879","doi":"https://doi.org/10.1016/s1569-1993(25)01722-9","title":"103 Restarting triple therapy with robust monitoring for adverse events (RETRIAL): a prospective, longitudinal, observational study of persons with CF initiating vanzacaftor/tezacaftor/deutivacaftor","display_name":"103 Restarting triple therapy with robust monitoring for adverse events (RETRIAL): a prospective, longitudinal, observational study of persons with CF initiating vanzacaftor/tezacaftor/deutivacaftor","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4414716879","doi":"https://doi.org/10.1016/s1569-1993(25)01722-9"},"language":"en","primary_location":{"id":"doi:10.1016/s1569-1993(25)01722-9","doi":"https://doi.org/10.1016/s1569-1993(25)01722-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1569-1993(25)01722-9","pdf_url":null,"source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091531715","display_name":"Christina Jayne Bathgate","orcid":"https://orcid.org/0000-0002-7120-2799","observed_orcids":["https://orcid.org/0000-0002-7120-2799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Bathgate","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063459032","display_name":"K. Riekert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Riekert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"K. Kirby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Kirby","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. Stoll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Stoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033941142","display_name":"Julia M. Boster","orcid":"https://orcid.org/0000-0002-3061-1449","observed_orcids":["https://orcid.org/0000-0002-3061-1449"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Boster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083639336","display_name":"Emma M. Tillman","orcid":"https://orcid.org/0000-0001-8019-9811","observed_orcids":["https://orcid.org/0000-0001-8019-9811","https://orcid.org/0000-0001-7485-3944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Tillman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019729863","display_name":"Lael M. Yonker","orcid":"https://orcid.org/0000-0003-1711-8227","observed_orcids":["https://orcid.org/0000-0003-1711-8227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Yonker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013299639","display_name":"Kevin J. Psoter","orcid":"https://orcid.org/0000-0001-8529-0585","observed_orcids":["https://orcid.org/0000-0001-8529-0585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Psoter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030037095","display_name":"Jiaojiao He","orcid":"https://orcid.org/0009-0005-3810-8150","observed_orcids":["https://orcid.org/0009-0005-3810-8150"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. He","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033647267","display_name":"A. Georgiopoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Georgiopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4370,"currency":"USD","value_usd":4370},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.29240128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":null,"first_page":"S54a","last_page":"S55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tezacaftor","display_name":"tezacaftor","score":1.0},{"id":"https://openalex.org/keywords/cftr-modulators","display_name":"CFTR modulators","score":0.8510000109672546},{"id":"https://openalex.org/keywords/treatment-restart","display_name":"treatment restart","score":0.531000018119812},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8759999871253967},{"id":"https://openalex.org/keywords/patient-monitoring","display_name":"patient monitoring","score":0.5490000247955322},{"id":"https://openalex.org/keywords/retrial","display_name":"retrial","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9696000218391418},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.8626999855041504},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6880999803543091},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5533000230789185},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.45019999146461487},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.4244000017642975},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2858000099658966},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2337999939918518},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22460000216960907},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.218299999833107}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1569-1993(25)01722-9","doi":"https://doi.org/10.1016/s1569-1993(25)01722-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1569-1993(25)01722-9","pdf_url":null,"source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7163146557","https://openalex.org/W7163169605","https://openalex.org/W4402235254","https://openalex.org/W7163169199","https://openalex.org/W7163187155","https://openalex.org/W4402234194","https://openalex.org/W4387746460","https://openalex.org/W4399046580","https://openalex.org/W7163223943","https://openalex.org/W4387746212"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}